CoChat

Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial

Lind, Nanna, Christensen, Merete B., Hansen, Dorte L., Nørgaard, Kirsten · 2024 · Diabetes Care
Cited by 71

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To compare the 12-month effects of continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) in adults with insulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: This is a single-center, parallel, open-label, randomized controlled trial including adults with inadequately controlled, insulin-treated type 2 diabetes from the outpatient clinic at Steno Diabetes Center Copenhagen, Denmark. Inclusion criteria were ≥18 years of age, insulin-treated type 2 diabetes, and HbA1c ≥7.5% (58 mmol/mol). Participants were randomly assigned (1:1) to 12 months of either CGM or BGM. All participants received a diabetes self-management education course and were followed by their usual health care providers. Primary outcome was between-group differences in change in time in range (TIR) 3.9–10.0 mmol/L, assessed at baseline, after 6 and 12 months by blinded CGM. The prespecified secondary outcomes were differences in change in several other glycemic, metabolic, and participant-reported outcomes. RESULTS: The 76 participants had a median baseline HbA1c of 8.3 (7.8, 9.1)% (67 [62–76] mmol/mol), and 61.8% were male. Compared with BGM, CGM usage was associated with significantly greater improvements in TIR (between-group difference 15.2%, 95% CI 4.6; 25.9), HbA1c (−0.9%, −1.4; −0.3 [−9.4 mmol/mol, −15.2; −3.5]), total daily insulin dose (−10.6 units/day, −19.9; −1.3), weight (−3.3 kg, −5.5; −1.1), and BMI (−1.1 kg/m2, −1.8; −0.3) and greater self-rated diabetes-related health, well-being, satisfaction, and health behavior. CONCLUSIONS: In adults with inadequately controlled insulin-treated type 2 diabetes, the 12-month impact of CGM was superior to BGM in improving glucose control and other crucial health parameters. The findings support the use of CGM in the insulin-treated subgroup of type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc23-2194

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 16

  1. Khunti, 2018, Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis, Diabetes Res Clin Pract, 137, 137, 10.1016/j.diabres.2017.12.004 · DOI · Paper page
  2. Venkatraman, 2022, Trends and disparities in glycemic control and severe hyperglycemia among US adults with diabetes using insulin, 1988-2020, JAMA Netw Open, 5, e2247656, 10.1001/jamanetworkopen.2022.47656 · DOI
  3. Karter, 2021, Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes, JAMA, 325, 2273, 10.1001/jama.2021.6530 · DOI · Paper page
  4. Lind, 2021, Real-time continuous glucose monitoring versus self-monitoring of blood glucose in adults with insulin-treated type 2 diabetes: a protocol for a randomised controlled single-centre trial, BMJ Open, 11, e040648, 10.1136/bmjopen-2020-040648 · DOI
  5. Lind, 2022, A new combined diabetes and CGM education program for adults with insulin-treated type 2 diabetes, Diabetes Technol Ther, 24, EP329
  6. Ware, 1992, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, 30, 473, 10.1097/00005650-199206000-00002 · DOI · Paper page
  7. Schmitt, 2016, How to assess diabetes distress: comparison of the problem areas in diabetes scale (paid) and the diabetes distress scale (DDS), Diabet Med, 33, 835, 10.1111/dme.12887 · DOI · Paper page
  8. Grabman, 2017, An empirically derived short form of the Hypoglycaemia Fear Survey II, Diabet Med, 34, 500, 10.1111/dme.13162 · DOI
  9. Polonsky, 2015, Development of a new measure for assessing glucose monitoring device-related treatment satisfaction and quality of life, Diabetes Technol Ther, 17, 657, 10.1089/dia.2014.0417 · DOI · Paper page
  10. Bradley, 1994, Guidelines for encouraging psychological well-being: report of a working group of the World Health Organization Regional Office for Europe and International Diabetes Federation European region St Vincent Declaration Action Programme for Diabetes, Diabet Med, 11, 510, 10.1111/j.1464-5491.1994.tb00316.x · DOI · Paper page
  11. Bradley, 2007, The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ, Health Qual Life Outcomes, 5, 57, 10.1186/1477-7525-5-57 · DOI · Paper page
  12. Saisho, 2018, Use of diabetes treatment satisfaction questionnaire in diabetes care: importance of patient-reported outcomes, Int J Environ Res Public Health, 15, 947, 10.3390/ijerph15050947 · DOI · Paper page
  13. Olsson, 2016, Categorical answer modes provide superior validity to open answers when asking for level of physical activity: a cross-sectional study, Scand J Public Health, 44, 70, 10.1177/1403494815602830 · DOI · Paper page
  14. Asaad, 2015, The reliability and validity of the perceived dietary adherence questionnaire for people with type 2 diabetes, Nutrients, 7, 5484, 10.3390/nu7075231 · DOI · Paper page
  15. Smith, 2023, Impact of missing data on the accuracy of glucose metrics from continuous glucose monitoring assessed over a 2-week period, Diabetes Technol Ther, 25, 356, 10.1089/dia.2022.0101 · DOI
  16. Isitt, 2022, Cost-effectiveness of a real-time continuous glucose monitoring system versus self-monitoring of blood glucose in people with type 2 diabetes on insulin therapy in the UK, Diabetes Ther, 13, 1875, 10.1007/s13300-022-01324-x · DOI

Cited by

See all 71

Metadata

Authors
Lind, N., Christensen, M. B., Hansen, D. L., & Nørgaard, K.
Affiliations
1Department of Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Venue
Diabetes Care
Published
2024-03-15
Volume
47
Issue
5
Pages
881-889
ISSN
  • 0149-5992
  • 1935-5548
Cited by
71
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.